Kodiak Sciences’ $90 Million Initial Public Offering

Wilson Sonsini Goodrich & Rosati is representing Kodiak in the offering Kodiak Sciences Inc. (Kodiak), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here